Equities

Jiangsu Bioperfectus Technologies Co Ltd

688399:SHH

Jiangsu Bioperfectus Technologies Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)69.00
  • Today's Change-0.88 / -1.26%
  • Shares traded367.84k
  • 1 Year change+25.82%
  • Beta--
Data delayed at least 15 minutes, as of Jul 04 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Jiangsu Bioperfectus Technologies Co Ltd is a China-based company mainly engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly include in vitro diagnostic reagents, supporting testing instruments and in vitro testing services. Its products are mainly used in the fields of infectious disease prevention and control, clinical testing, large-scale population screening, as well as prenatal and postnatal care management. The Company mainly conducts its businesses in domestic and overseas markets.

  • Revenue in CNY (TTM)400.25m
  • Net income in CNY-314.32m
  • Incorporated2010
  • Employees684.00
  • Location
    Jiangsu Bioperfectus Technologies Co LtdNo. 837, Yaocheng AvenueTAIZHOU 225300ChinaCHN
  • Phone+86 52 380225599
  • Fax+86 52 386201617
  • Websitehttps://www.bioperfectus.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hangzhou Alltest Biotech Co Ltd718.48m184.83m3.71bn1.09k20.100.9468--5.162.332.339.0249.430.1652.136.17657,349.004.2423.354.5726.8346.8358.3425.6939.0710.16--0.005629.79-77.7332.59-84.7526.1972.77--
Getein Biotech Inc1.31bn244.26m3.91bn2.14k16.011.48--2.990.48160.48162.585.220.35021.612.77611,337.706.6313.259.2418.4566.1365.5718.9228.131.97--0.185729.88-24.8514.81-43.922.3118.446.00
Hangzhou Ags Medtech Co Ltd529.86m235.79m3.95bn592.0016.801.76--7.462.912.916.5427.800.37753.3613.43895,039.9016.80--17.73--70.24--44.50--24.45--0.0054--37.09--49.87------
SWS Hemodialysis Care Co Ltd659.16m154.15m4.06bn881.0026.322.36--6.150.71480.71483.067.970.33512.115.56748,197.707.71--8.68--50.81--23.00--15.96--0.0089--80.65--228.34------
Jiangsu Bioperfectus Technologies Co Ltd400.25m-314.32m4.10bn684.00--1.19--10.23-5.36-5.366.8358.770.09150.85921.57585,153.50-7.1925.41-8.3631.2663.2063.37-78.5332.866.05--0.08630.54-92.7211.81-120.45--2.43--
Shanghai Sanyou Medical Co Ltd385.98m58.83m4.19bn466.0073.982.19--10.860.2280.2281.537.710.16990.58912.20828,288.803.299.423.8610.8571.5287.1519.3429.783.35--0.029116.21-29.0815.67-49.918.99-15.60--
Assure Tech Hangzhou Co Ltd511.29m160.91m4.27bn791.0026.540.8245--8.351.271.274.0240.750.07991.522.67646,379.602.5131.832.9438.9738.5665.8231.4747.868.26--0.016616.05-91.8425.18-95.3533.5178.77--
Qingdao NovelBeam Technology Co Ltd439.81m135.69m4.40bn797.0032.313.30--10.001.121.123.6210.950.31381.084.50551,832.809.4514.6710.0716.6362.5462.3230.1134.1511.88--0.003933.55-1.3118.58-20.1921.7110.45--
Zhejiang Gongdong Medical Techno Co Ltd1.02bn125.32m4.42bn1.67k35.212.62--4.331.111.119.0714.980.54476.004.59609,805.406.6916.357.4619.2631.1341.1912.2821.623.85--0.020138.99-33.6115.11-66.535.1427.71--
Data as of Jul 04 2024. Currency figures normalised to Jiangsu Bioperfectus Technologies Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

8.57%Per cent of shares held by top holders
HolderShares% Held
Rongtong Fund Management Co., Ltd.as of 31 Dec 20232.72m4.63%
GF Fund Management Co., Ltd.as of 31 Dec 20231.58m2.70%
Huatai-PineBridge Fund Management Co., Ltd.as of 31 Dec 2023255.82k0.44%
Lion Fund Management Co., Ltd.as of 31 Dec 2023188.37k0.32%
Maxwealth Fund Management Co., Ltd.as of 31 Dec 2023116.87k0.20%
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 202361.47k0.11%
Dimensional Fund Advisors LPas of 06 Jun 202452.99k0.09%
Manulife TEDA Fund Management Co., Ltd.as of 31 Dec 202319.85k0.03%
China Merchants Fund Management Co., Ltd.as of 31 Dec 202316.71k0.03%
Wanjia Asset Management Co., Ltd.as of 31 Dec 202315.31k0.03%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.